The legacy of Viagra, and its parent company copyright, presents a complex case study for investors. At first a blockbuster drug, generating billions in revenue , its exclusivity period created a wave of knock-off medications, significantly impacting its dominance. While certain pharmaceutical companies may seek to capitalize on related treatments